Monoclonal antibodies have been around for decades. Antibody medicines like the one that earned President Donald Trump's praise after treatment earlier this month are not just for COVID-19. For the ...

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation... Low Demand For Antibody Drugs Against COVID-19 Federal ...

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...

The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

Please provide your email address to receive an email when new articles are posted on . Monoclonal antibodies decrease inflammation in the immune system by binding to ...

Exposure to multiple sclerosis (MS) monoclonal antibody treatment during breastfeeding appeared to have no negative effect on the early development or health of infants, registry data in Germany ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

A promising new drug could prevent and even reverse the onset of type 1 diabetes. The experimental monoclonal antibody drug was found to act like a shield to protect insulin-producing cells from ...

(CNN) — The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead by ...